AMI Organics has announced that the Pharmaceutical and Medical Devices Agency (PMDA) Japan has declared its Sachin manufacturing facility in Surat as compliant with Good Manufacturing Practices (GMP). This announcement follows an earlier update from the company on June 7, 2024, regarding the completion of the GMP inspection at the Sachin facility.
The inspection was conducted to ensure that the facility meets the required manufacturing standards, and the positive result reaffirms the company’s commitment to maintaining high-quality production practices. This certification is expected to enhance AMI Organics’ reputation and expand its footprint in global markets.
TOPICS:
Ami Organics